Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Efficacy of CBD (Epidiolex) in Idiopathic Generalized Epilepsy With Typical Absence Seizures

Trial Profile

Safety and Efficacy of CBD (Epidiolex) in Idiopathic Generalized Epilepsy With Typical Absence Seizures

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Absence epilepsy; Generalised epilepsy; Seizures; Tonic-clonic epilepsy
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jul 2023 Timeline for primary efficacy end-point has been reduced from 120 days to 90 days. Lower age limit has been reduced from 16 years to 6 years and upper age limit has been waived off from the inclusion criteria.
    • 09 Jul 2023 Status changed from recruiting to completed.
    • 06 Dec 2022 Results (n=9) reporting efficacy and QOLIE score data presented at the 76th Annual Meeting of the American Epilepsy Society
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top